Attached files
| file | filename |
|---|---|
| EX-32.2 - HARROW HEALTH, INC. | ex32-2.htm |
| EX-32.1 - HARROW HEALTH, INC. | ex32-1.htm |
| EX-32.2 - HARROW HEALTH, INC. | ex31-2.htm |
| EX-31.1 - HARROW HEALTH, INC. | ex31-1.htm |
| EX-21.1 - HARROW HEALTH, INC. | ex21-1.htm |
| 10-K - HARROW HEALTH, INC. | form10-k.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-159159, 333-183488 and 333-198674 on Form S-8 and Registration Statement Nos. 333-198675 and 333-215672 on Form S-3 of our report dated March 21, 2017, relating to the consolidated financial statements of Imprimis Pharmaceuticals, Inc. and subsidiaries, appearing in this Annual Report on Form 10-K of Imprimis Pharmaceuticals, Inc. for the year ended December 31, 2016.
| /s/ KMJ Corbin & Company LLP | |
| Costa Mesa, California | |
| March 21, 2017 |